University of Pittsburgh researchers uncover mitochondrial defect involved with inherited cancers

PITTSBURGH, Feb. 3 -- University of Pittsburgh researchers have uncovered a major new concept of how a certain type of tumor develops by linking a specific defect in mitochondria to a type of inherited tumor.

The Pitt scientists, led by Bora E. Baysal, M.D., Ph.D. and Bernie Devlin, Ph.D., department of psychiatry, found that a defective gene on chromosome 11q23, a region previously implicated in the progression of many solid cancerous tumors, causes a hereditary tumor called hereditary paraganglioma. Paraganglioma tumors most commonly occur in the carotid body, a small organ located in the carotid artery in the neck that senses blood oxygen levels. This discovery is important because for the first time it ties a genetic defect in mitochondria (energy producing organelles inside the cell) to tumor development.

Results of the study appear in today's issue of the journal Science.

The researchers became interested in families with paraganglioma who show a peculiar inheritance pattern, which can be explained by a process called "genomic imprinting." While the genetic defect is transmitted through both mothers and fathers, tumors develop only when fathers transmit the defect. The researchers found that a gene named succinate-ubiquinone oxido-reductase (SDHD), that codes for an integral part of mitochondrial complex II, was defective in families with paraganglioma. By the researchers' reasoning, the defect is likely to cause mitochondria to fail to properly sense the oxygen levels in the cell. And, because of the oxygen-sensing defect, the carotid body is chronically stimulated to compensate for the lack of oxygen. This chronic stimulation eventually leads to cellular proliferation and tumor development. Chronic atmospheric hypoxia (reduced oxygen level) was previously linked to the development of paraganglioma tumors in people living at high altitud es.

It is conceivable, argue the researchers, that defect

Contact: Craig Dunhoff
University of Pittsburgh Medical Center

Page: 1 2

Related biology news :

1. Indiana University, EPA to study airborne PCBs
2. University of Alberta researcher looks for clues to mysterious disease
3. Northeastern University receives $12.4 million NSF grant for creation of nanomanufacturing institute
4. Washington University in St. Louis leads group studying aging process
5. Tufts University establishes $4 million dollar tissue engineering resource center
6. Case for IBD combination therapy comes from research at Baylor, MIT and Hebrew University
7. As informatics grows, Indiana University helps set research agenda
8. University of Arizona licenses patent for natural fungicide
9. Washington University in St. Louis plays key role in sequencing moss genome
10. University of Pittsburgh receives $10 million grant for head and neck cancer
11. Clemson University spin-off uses corn to make plastics, provide cleaner air

Post Your Comments:

(Date:1/14/2019)... ... 2019 , ... CellMax Life , a diagnostics company ... present new findings at the ASCO Gastrointestinal Cancer Symposium in San Francisco this ... this study show CellMax Life’s blood test, based on its proprietary CMxTM platform, ...
(Date:1/10/2019)... ... January 10, 2019 , ... ... gap between inexpensive in vitro studies and significantly more expensive in vivo studies ... efficacy and toxicity. To address this need, researchers have begun to adopt 3D ...
(Date:1/7/2019)... ... , ... Concerto HealthAI, a technology leader in definitive Real ... other key therapeutic areas, and its Chief Executive Officer, Dr. Jeff Elton, will ... entire healthcare landscape, on January 8, 2019, at 2:30 p.m. in San Francisco, ...
Breaking Biology News(10 mins):
(Date:1/24/2019)... , ... January 22, 2019 , ... ... each trial has its own set of assumptions, and RFP creation and management ... evaluating bids is like comparing apples to oranges. These challenges can ultimately lead ...
(Date:1/21/2019)... , ... January 21, 2019 , ... ... newest product line, SporActiv™, for the industrial and institutional cleaning market. MDG’s SporActiv ... residential and commercial cleaning needs. Applications include odor control, floor and tile cleaners, ...
(Date:1/20/2019)... NEW YORK (PRWEB) , ... January 17, 2019 ... ... ordering clinical testing was, until recently, the exclusive purview of physicians. That's changing ... okay. The global direct to consumer (DTC) laboratory testing market totaled $208 million ...
(Date:1/20/2019)... , ... January 17, 2019 , ... ... Platinum Partner announces the launch of a specialized automation technology, titled Automate 3D. ... for automatic generation of models and drawings to deliver to end-users, customers, and ...
Breaking Biology Technology:
Cached News: